Prosthetic Valve Endocarditis After TAVR and SAVR | Zendy

Matthew R. Summers | Zendy; Martin B. Leon | Zendy; Craig R. Smith | Zendy; Susheel Kodali | Zendy; Vinod H. Thourani | Zendy; Hartmut Herrmann | Zendy; Raj Makkar | Zendy; Philippe Pîbarot | Zendy; John G. Webb | Zendy; Jonathon Leipsic | Zendy; Maria Alu | Zendy; Aaron Crowley | Zendy; Rebecca T. Hahn | Zendy; Samir Kapadia | Zendy; E. Murat Tuzcu | Zendy; Lars G. Svensson | Zendy; Paul Cremer | Zendy; Wael A. Jaber | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prosthetic Valve Endocarditis After TAVR and SAVR

Author(s) -

Matthew R. Summers,

Martin B. Leon,

Craig R. Smith,

Susheel Kodali,

Vinod H. Thourani,

Hartmut Herrmann,

Raj Makkar,

Philippe Pîbarot,

John G. Webb,

Jonathon Leipsic,

Maria Alu,

Aaron Crowley,

Rebecca T. Hahn,

Samir Kapadia,

E. Murat Tuzcu,

Lars G. Svensson,

Paul Cremer,

Wael A. Jaber

Publication year - 2019

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.119.041399

Subject(s) - medicine , hazard ratio , valve replacement , aortic valve replacement , cardiology , incidence (geometry) , aortic valve stenosis , endocarditis , aortic valve , rate ratio , surgery , stenosis , confidence interval , physics , optics

Prosthetic valve endocarditis (PVE) is a rare but critical mechanism of valve failure and death after transcatheter and surgical aortic valve replacement (TAVR, SAVR) warranting further analysis in modern aortic valve replacement experience. We characterize the incidence, risk factors, microbiological profile and outcomes of PVE from the PARTNER trials and registries (Placement of Aortic Transcatheter Valve).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research